PDB Short entry for 1D7W HEADER OXIDOREDUCTASE 20-OCT-99 1D7W TITLE CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C COMPLEXED WITH TITLE 2 CYANIDE AND BROMIDE AT PH 4.0 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYELOPEROXIDASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGHT CHAIN; COMPND 5 EC: 1.11.1.7; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: MYELOPEROXIDASE; COMPND 8 CHAIN: C, D; COMPND 9 FRAGMENT: HEAVY CHAIN; COMPND 10 EC: 1.11.1.7 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 CELL: NEUTROPHIL; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 TISSUE: BLOOD; SOURCE 12 CELL: NEUTROPHIL KEYWDS HEME-PROTEIN, PEROXIDASE, OXIDOREDUCTASE, PEROXIDASE-CYANIDE-BROMIDE KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.J.FIEDLER,R.E.FENNA REVDAT 5 29-JUL-20 1D7W 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 1D7W 1 VERSN REVDAT 3 24-FEB-09 1D7W 1 VERSN REVDAT 2 01-APR-03 1D7W 1 JRNL REVDAT 1 12-DEC-01 1D7W 0 JRNL AUTH M.BLAIR-JOHNSON,T.FIEDLER,R.FENNA JRNL TITL HUMAN MYELOPEROXIDASE: STRUCTURE OF A CYANIDE COMPLEX AND JRNL TITL 2 ITS INTERACTION WITH BROMIDE AND THIOCYANATE SUBSTRATES AT JRNL TITL 3 1.9 A RESOLUTION. JRNL REF BIOCHEMISTRY V. 40 13990 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11705390 JRNL DOI 10.1021/BI0111808 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.FENNA,J.ZENG,C.DAVEY REMARK 1 TITL STRUCTURE OF THE GREEN HEME IN MYELOPEROXIDASE REMARK 1 REF ARCH.BIOCHEM.BIOPHYS. V. 316 653 1995 REMARK 1 REFN ISSN 0003-9861 REMARK 1 DOI 10.1006/ABBI.1995.1086 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.A.DAVEY,R.E.FENNA REMARK 1 TITL 2.3 ANGSTROM RESOLUTION X-RAY CRYSTAL STRUCTURE OF THE REMARK 1 TITL 2 BISUBSTRATE ANALOGUE INHIBITOR SALICYLHYDROXAMIC ACID BOUND REMARK 1 TITL 3 TO HUMAN MYELOPEROXIDASE: A MODEL FOR A PREREACTION COMPLEX REMARK 1 TITL 4 WITH HYDROGEN PEROXIDE REMARK 1 REF BIOCHEMISTRY V. 35 10967 1996 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI960577M REMARK 1 REFERENCE 3 REMARK 1 AUTH J.ZENG,R.E.FENNA REMARK 1 TITL X-RAY CRYSTAL STRUCTURE OF CANINE MYELOPEROXIDASE AT 3 REMARK 1 TITL 2 ANGSTROM RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 226 185 1992 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 4 REMARK 1 AUTH A.JACQUET,L.GARCIA-QUINTANA,V.DELEERSNYDER,R.FENNA,A.BOLLEN, REMARK 1 AUTH 2 N.MOGUILEVSKY REMARK 1 TITL SITE-DIRECTED MUTAGENESIS OF HUMAN MYELOPEROXIDASE: FURTHER REMARK 1 TITL 2 IDENTIFICATION OF RESIDUES INVOLVED IN CATALYTIC ACTIVITY REMARK 1 TITL 3 AND HEME INTERACTION REMARK 1 REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 202 73 1994 REMARK 1 REFN ISSN 0006-291X REMARK 1 DOI 10.1006/BBRC.1994.1895 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.9 REMARK 3 NUMBER OF REFLECTIONS : 88542 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM 5% REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4477 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7308 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE : 0.3024 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 388 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9142 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 371 REMARK 3 SOLVENT ATOMS : 806 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.280 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.18 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.190 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1D7W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-NOV-99. REMARK 100 THE DEPOSITION ID IS D_1000009874. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUN-99 REMARK 200 TEMPERATURE (KELVIN) : 84.0 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : LONG FOCUSING MIRRORS, ADSC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 92679 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 3.710 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.8900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.89 REMARK 200 R MERGE FOR SHELL (I) : 0.19100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.890 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: POLYETHYLENE GLYCOL 8000, AMMONIUM REMARK 280 SULFATE, SODIUM ACETATE, CALCIUM ACETATE, SODIUM CYANIDE, SODIUM REMARK 280 BROMIDE, PH 4.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.66200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, B, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -88.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16620 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -100.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LYS A 6 O HOH A 726A 1.75 REMARK 500 C CYN A 1844 NB HEM A 605 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 HIS D 336 CE1 - NE2 - CD2 ANGL. DEV. = 4.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 2 140.75 -38.07 REMARK 500 PRO A 20 -4.00 -59.32 REMARK 500 PHE A 41 -9.84 -140.43 REMARK 500 SER A 42 -49.60 -156.99 REMARK 500 ASN C 114 105.50 55.46 REMARK 500 ARG C 136 -54.40 -127.45 REMARK 500 ASP C 142 -166.40 -65.10 REMARK 500 ILE C 158 -47.96 -131.94 REMARK 500 HIS C 217 -77.65 -75.48 REMARK 500 ASP C 218 76.41 -106.10 REMARK 500 ASP C 318 2.12 -69.31 REMARK 500 ARG C 333 6.30 -69.32 REMARK 500 ASN C 457 98.38 -167.28 REMARK 500 ASN C 555 10.09 -158.18 REMARK 500 LYS B 6 -32.32 -137.44 REMARK 500 PHE B 41 -11.85 -147.89 REMARK 500 SER B 42 -39.67 -158.39 REMARK 500 ARG D 136 -50.16 -126.55 REMARK 500 HIS D 217 -70.52 -68.81 REMARK 500 ASP D 218 32.40 -97.91 REMARK 500 ASP D 219 108.99 -19.76 REMARK 500 ASN D 225 99.73 -171.63 REMARK 500 ASP D 272 -177.82 -69.17 REMARK 500 ARG D 314 -74.01 -105.74 REMARK 500 ASN D 457 95.26 -165.35 REMARK 500 ASN D 555 10.75 -165.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA C1600 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 96 O REMARK 620 2 ASP A 96 OD2 76.0 REMARK 620 3 THR C 168 O 72.1 146.0 REMARK 620 4 THR C 168 OG1 135.1 143.3 70.6 REMARK 620 5 PHE C 170 O 106.3 79.7 98.0 102.9 REMARK 620 6 ASP C 172 OD1 145.0 70.5 142.7 74.4 77.5 REMARK 620 7 SER C 174 OG 84.1 78.5 109.3 85.3 152.7 79.8 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 605 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYN A1844 C REMARK 620 2 HEM A 605 NA 91.3 REMARK 620 3 HEM A 605 NB 65.8 90.4 REMARK 620 4 HEM A 605 NC 85.2 176.1 89.7 REMARK 620 5 HEM A 605 ND 98.9 89.2 164.7 89.7 REMARK 620 6 CYN A1844 N 20.6 80.9 83.8 95.3 81.0 REMARK 620 7 HIS C 336 NE2 165.2 93.2 100.1 90.5 95.2 173.0 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA D2600 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 96 O REMARK 620 2 ASP B 96 OD2 72.4 REMARK 620 3 THR D 168 O 77.6 149.5 REMARK 620 4 THR D 168 OG1 141.0 137.8 71.6 REMARK 620 5 PHE D 170 O 100.3 83.6 96.3 106.3 REMARK 620 6 ASP D 172 OD1 143.5 71.2 138.8 71.3 77.6 REMARK 620 7 SER D 174 OG 87.8 74.0 110.8 81.4 152.8 80.6 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 605 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYN B2844 C REMARK 620 2 HEM B 605 NA 86.9 REMARK 620 3 HEM B 605 NB 74.0 91.1 REMARK 620 4 HEM B 605 NC 90.7 177.3 89.2 REMARK 620 5 HEM B 605 ND 94.5 89.3 168.5 89.8 REMARK 620 6 CYN B2844 N 16.7 79.0 89.1 98.3 79.7 REMARK 620 7 HIS D 336 NE2 169.0 92.9 95.0 89.7 96.5 171.1 REMARK 620 N 1 2 3 4 5 6 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MHL RELATED DB: PDB REMARK 900 1MHL CONTAINS THE NATIVE PROTEIN STRUCTURE SOLVED TO 2.25 ANGSTROMS REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1MYP RELATED DB: PDB REMARK 900 1MYP CONTAINS THE CANINE MYELOPEROXIDASE STRUCTURE AT 3.0 ANGSTROMS REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1CXP RELATED DB: PDB REMARK 900 1CXP CONTAINS THE CRYOGENIC NATIVE PROTEIN STRUCTURE TO 1.80 REMARK 900 ANGSTROMS RESOLUTION REMARK 900 RELATED ID: 1D2V RELATED DB: PDB REMARK 900 1D2V CONTAINS THE BROMIDE-BOUND HUMAN MYELOPEROXIDASE AT 1.75 REMARK 900 ANGSTROMS RESOLUTION REMARK 900 RELATED ID: 1D5L RELATED DB: PDB REMARK 900 1D5L CONTAINS THE CYANIDE-BOUND HUMAN MYELOPEROXIDASE AT 1.90 REMARK 900 ANGSTROMS RESOLUTION DBREF 1D7W A 1 104 UNP P05164 PERM_HUMAN 167 270 DBREF 1D7W B 1 104 UNP P05164 PERM_HUMAN 167 270 DBREF 1D7W C 113 578 UNP P05164 PERM_HUMAN 279 744 DBREF 1D7W D 113 578 UNP P05164 PERM_HUMAN 279 744 SEQADV 1D7W CSO C 150 UNP P05164 CYS 315 MODIFIED RESIDUE SEQADV 1D7W CSO D 150 UNP P05164 CYS 315 MODIFIED RESIDUE SEQRES 1 A 104 CYS PRO GLU GLN ASP LYS TYR ARG THR ILE THR GLY MET SEQRES 2 A 104 CYS ASN ASN ARG ARG SER PRO THR LEU GLY ALA SER ASN SEQRES 3 A 104 ARG ALA PHE VAL ARG TRP LEU PRO ALA GLU TYR GLU ASP SEQRES 4 A 104 GLY PHE SER LEU PRO TYR GLY TRP THR PRO GLY VAL LYS SEQRES 5 A 104 ARG ASN GLY PHE PRO VAL ALA LEU ALA ARG ALA VAL SER SEQRES 6 A 104 ASN GLU ILE VAL ARG PHE PRO THR ASP GLN LEU THR PRO SEQRES 7 A 104 ASP GLN GLU ARG SER LEU MET PHE MET GLN TRP GLY GLN SEQRES 8 A 104 LEU LEU ASP HIS ASP LEU ASP PHE THR PRO GLU PRO ALA SEQRES 1 C 466 VAL ASN CYS GLU THR SER CYS VAL GLN GLN PRO PRO CYS SEQRES 2 C 466 PHE PRO LEU LYS ILE PRO PRO ASN ASP PRO ARG ILE LYS SEQRES 3 C 466 ASN GLN ALA ASP CYS ILE PRO PHE PHE ARG SER CSO PRO SEQRES 4 C 466 ALA CYS PRO GLY SER ASN ILE THR ILE ARG ASN GLN ILE SEQRES 5 C 466 ASN ALA LEU THR SER PHE VAL ASP ALA SER MET VAL TYR SEQRES 6 C 466 GLY SER GLU GLU PRO LEU ALA ARG ASN LEU ARG ASN MET SEQRES 7 C 466 SER ASN GLN LEU GLY LEU LEU ALA VAL ASN GLN ARG PHE SEQRES 8 C 466 GLN ASP ASN GLY ARG ALA LEU LEU PRO PHE ASP ASN LEU SEQRES 9 C 466 HIS ASP ASP PRO CYS LEU LEU THR ASN ARG SER ALA ARG SEQRES 10 C 466 ILE PRO CYS PHE LEU ALA GLY ASP THR ARG SER SER GLU SEQRES 11 C 466 MET PRO GLU LEU THR SER MET HIS THR LEU LEU LEU ARG SEQRES 12 C 466 GLU HIS ASN ARG LEU ALA THR GLU LEU LYS SER LEU ASN SEQRES 13 C 466 PRO ARG TRP ASP GLY GLU ARG LEU TYR GLN GLU ALA ARG SEQRES 14 C 466 LYS ILE VAL GLY ALA MET VAL GLN ILE ILE THR TYR ARG SEQRES 15 C 466 ASP TYR LEU PRO LEU VAL LEU GLY PRO THR ALA MET ARG SEQRES 16 C 466 LYS TYR LEU PRO THR TYR ARG SER TYR ASN ASP SER VAL SEQRES 17 C 466 ASP PRO ARG ILE ALA ASN VAL PHE THR ASN ALA PHE ARG SEQRES 18 C 466 TYR GLY HIS THR LEU ILE GLN PRO PHE MET PHE ARG LEU SEQRES 19 C 466 ASP ASN ARG TYR GLN PRO MET GLU PRO ASN PRO ARG VAL SEQRES 20 C 466 PRO LEU SER ARG VAL PHE PHE ALA SER TRP ARG VAL VAL SEQRES 21 C 466 LEU GLU GLY GLY ILE ASP PRO ILE LEU ARG GLY LEU MET SEQRES 22 C 466 ALA THR PRO ALA LYS LEU ASN ARG GLN ASN GLN ILE ALA SEQRES 23 C 466 VAL ASP GLU ILE ARG GLU ARG LEU PHE GLU GLN VAL MET SEQRES 24 C 466 ARG ILE GLY LEU ASP LEU PRO ALA LEU ASN MET GLN ARG SEQRES 25 C 466 SER ARG ASP HIS GLY LEU PRO GLY TYR ASN ALA TRP ARG SEQRES 26 C 466 ARG PHE CYS GLY LEU PRO GLN PRO GLU THR VAL GLY GLN SEQRES 27 C 466 LEU GLY THR VAL LEU ARG ASN LEU LYS LEU ALA ARG LYS SEQRES 28 C 466 LEU MET GLU GLN TYR GLY THR PRO ASN ASN ILE ASP ILE SEQRES 29 C 466 TRP MET GLY GLY VAL SER GLU PRO LEU LYS ARG LYS GLY SEQRES 30 C 466 ARG VAL GLY PRO LEU LEU ALA CYS ILE ILE GLY THR GLN SEQRES 31 C 466 PHE ARG LYS LEU ARG ASP GLY ASP ARG PHE TRP TRP GLU SEQRES 32 C 466 ASN GLU GLY VAL PHE SER MET GLN GLN ARG GLN ALA LEU SEQRES 33 C 466 ALA GLN ILE SER LEU PRO ARG ILE ILE CYS ASP ASN THR SEQRES 34 C 466 GLY ILE THR THR VAL SER LYS ASN ASN ILE PHE MET SER SEQRES 35 C 466 ASN SER TYR PRO ARG ASP PHE VAL ASN CYS SER THR LEU SEQRES 36 C 466 PRO ALA LEU ASN LEU ALA SER TRP ARG GLU ALA SEQRES 1 B 104 CYS PRO GLU GLN ASP LYS TYR ARG THR ILE THR GLY MET SEQRES 2 B 104 CYS ASN ASN ARG ARG SER PRO THR LEU GLY ALA SER ASN SEQRES 3 B 104 ARG ALA PHE VAL ARG TRP LEU PRO ALA GLU TYR GLU ASP SEQRES 4 B 104 GLY PHE SER LEU PRO TYR GLY TRP THR PRO GLY VAL LYS SEQRES 5 B 104 ARG ASN GLY PHE PRO VAL ALA LEU ALA ARG ALA VAL SER SEQRES 6 B 104 ASN GLU ILE VAL ARG PHE PRO THR ASP GLN LEU THR PRO SEQRES 7 B 104 ASP GLN GLU ARG SER LEU MET PHE MET GLN TRP GLY GLN SEQRES 8 B 104 LEU LEU ASP HIS ASP LEU ASP PHE THR PRO GLU PRO ALA SEQRES 1 D 466 VAL ASN CYS GLU THR SER CYS VAL GLN GLN PRO PRO CYS SEQRES 2 D 466 PHE PRO LEU LYS ILE PRO PRO ASN ASP PRO ARG ILE LYS SEQRES 3 D 466 ASN GLN ALA ASP CYS ILE PRO PHE PHE ARG SER CSO PRO SEQRES 4 D 466 ALA CYS PRO GLY SER ASN ILE THR ILE ARG ASN GLN ILE SEQRES 5 D 466 ASN ALA LEU THR SER PHE VAL ASP ALA SER MET VAL TYR SEQRES 6 D 466 GLY SER GLU GLU PRO LEU ALA ARG ASN LEU ARG ASN MET SEQRES 7 D 466 SER ASN GLN LEU GLY LEU LEU ALA VAL ASN GLN ARG PHE SEQRES 8 D 466 GLN ASP ASN GLY ARG ALA LEU LEU PRO PHE ASP ASN LEU SEQRES 9 D 466 HIS ASP ASP PRO CYS LEU LEU THR ASN ARG SER ALA ARG SEQRES 10 D 466 ILE PRO CYS PHE LEU ALA GLY ASP THR ARG SER SER GLU SEQRES 11 D 466 MET PRO GLU LEU THR SER MET HIS THR LEU LEU LEU ARG SEQRES 12 D 466 GLU HIS ASN ARG LEU ALA THR GLU LEU LYS SER LEU ASN SEQRES 13 D 466 PRO ARG TRP ASP GLY GLU ARG LEU TYR GLN GLU ALA ARG SEQRES 14 D 466 LYS ILE VAL GLY ALA MET VAL GLN ILE ILE THR TYR ARG SEQRES 15 D 466 ASP TYR LEU PRO LEU VAL LEU GLY PRO THR ALA MET ARG SEQRES 16 D 466 LYS TYR LEU PRO THR TYR ARG SER TYR ASN ASP SER VAL SEQRES 17 D 466 ASP PRO ARG ILE ALA ASN VAL PHE THR ASN ALA PHE ARG SEQRES 18 D 466 TYR GLY HIS THR LEU ILE GLN PRO PHE MET PHE ARG LEU SEQRES 19 D 466 ASP ASN ARG TYR GLN PRO MET GLU PRO ASN PRO ARG VAL SEQRES 20 D 466 PRO LEU SER ARG VAL PHE PHE ALA SER TRP ARG VAL VAL SEQRES 21 D 466 LEU GLU GLY GLY ILE ASP PRO ILE LEU ARG GLY LEU MET SEQRES 22 D 466 ALA THR PRO ALA LYS LEU ASN ARG GLN ASN GLN ILE ALA SEQRES 23 D 466 VAL ASP GLU ILE ARG GLU ARG LEU PHE GLU GLN VAL MET SEQRES 24 D 466 ARG ILE GLY LEU ASP LEU PRO ALA LEU ASN MET GLN ARG SEQRES 25 D 466 SER ARG ASP HIS GLY LEU PRO GLY TYR ASN ALA TRP ARG SEQRES 26 D 466 ARG PHE CYS GLY LEU PRO GLN PRO GLU THR VAL GLY GLN SEQRES 27 D 466 LEU GLY THR VAL LEU ARG ASN LEU LYS LEU ALA ARG LYS SEQRES 28 D 466 LEU MET GLU GLN TYR GLY THR PRO ASN ASN ILE ASP ILE SEQRES 29 D 466 TRP MET GLY GLY VAL SER GLU PRO LEU LYS ARG LYS GLY SEQRES 30 D 466 ARG VAL GLY PRO LEU LEU ALA CYS ILE ILE GLY THR GLN SEQRES 31 D 466 PHE ARG LYS LEU ARG ASP GLY ASP ARG PHE TRP TRP GLU SEQRES 32 D 466 ASN GLU GLY VAL PHE SER MET GLN GLN ARG GLN ALA LEU SEQRES 33 D 466 ALA GLN ILE SER LEU PRO ARG ILE ILE CYS ASP ASN THR SEQRES 34 D 466 GLY ILE THR THR VAL SER LYS ASN ASN ILE PHE MET SER SEQRES 35 D 466 ASN SER TYR PRO ARG ASP PHE VAL ASN CYS SER THR LEU SEQRES 36 D 466 PRO ALA LEU ASN LEU ALA SER TRP ARG GLU ALA MODRES 1D7W ASN C 317 ASN GLYCOSYLATION SITE MODRES 1D7W ASN C 189 ASN GLYCOSYLATION SITE MODRES 1D7W ASN C 225 ASN GLYCOSYLATION SITE MODRES 1D7W ASN D 317 ASN GLYCOSYLATION SITE MODRES 1D7W ASN D 189 ASN GLYCOSYLATION SITE MODRES 1D7W ASN D 225 ASN GLYCOSYLATION SITE MODRES 1D7W CSO C 150 CYS S-HYDROXYCYSTEINE MODRES 1D7W CSO D 150 CYS S-HYDROXYCYSTEINE HET CSO C 150 7 HET CSO D 150 7 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET MAN E 4 11 HET MAN E 5 11 HET FUC E 6 10 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET MAN F 4 11 HET MAN F 5 11 HET FUC F 6 10 HET BR A1601 1 HET SO4 A1602 5 HET CYN A1844 2 HET ACT A2608 4 HET HEM A 605 43 HET NAG C1620 14 HET NAG C1630 14 HET CA C1600 1 HET SO4 C1603 5 HET SO4 C1610 5 HET ACT C1606 4 HET ACT C1604 4 HET ACT C1607 4 HET ACT C1609 4 HET ACT C1612 4 HET BR C 758A 1 HET BR C 889A 1 HET BR C 957A 1 HET ACT B1608 4 HET BR B2601 1 HET SO4 B2602 5 HET ACT B2611 4 HET CYN B2844 2 HET HEM B 605 43 HET NAG D2620 14 HET NAG D2630 14 HET CA D2600 1 HET SO4 D2610 5 HET ACT D2606 4 HET ACT D2604 4 HET ACT D2607 4 HET ACT D2609 4 HET BR D 758B 1 HET BR D 889B 1 HET BR D 957B 1 HETNAM CSO S-HYDROXYCYSTEINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM BR BROMIDE ION HETNAM SO4 SULFATE ION HETNAM CYN CYANIDE ION HETNAM ACT ACETATE ION HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM CA CALCIUM ION HETSYN HEM HEME FORMUL 2 CSO 2(C3 H7 N O3 S) FORMUL 5 NAG 8(C8 H15 N O6) FORMUL 5 BMA 2(C6 H12 O6) FORMUL 5 MAN 4(C6 H12 O6) FORMUL 5 FUC 2(C6 H12 O5) FORMUL 7 BR 8(BR 1-) FORMUL 8 SO4 5(O4 S 2-) FORMUL 9 CYN 2(C N 1-) FORMUL 10 ACT 12(C2 H3 O2 1-) FORMUL 11 HEM 2(C34 H32 FE N4 O4) FORMUL 14 CA 2(CA 2+) FORMUL 42 HOH *806(H2 O) HELIX 1 1 LEU A 60 VAL A 69 1 10 HELIX 2 2 PRO A 72 LEU A 76 5 5 HELIX 3 3 LEU A 84 ASP A 98 1 15 HELIX 4 4 ALA C 173 GLY C 178 1 6 HELIX 5 5 GLU C 180 ARG C 188 1 9 HELIX 6 6 ASP C 219 ASN C 225 1 7 HELIX 7 7 MET C 243 ASN C 268 1 26 HELIX 8 8 ASP C 272 ASP C 295 1 24 HELIX 9 9 TYR C 296 GLY C 302 1 7 HELIX 10 10 GLY C 302 LEU C 310 1 9 HELIX 11 11 ALA C 325 PHE C 332 1 8 HELIX 12 12 ARG C 333 ILE C 339 5 7 HELIX 13 13 SER C 362 VAL C 364 5 3 HELIX 14 14 SER C 368 GLU C 374 1 7 HELIX 15 15 ILE C 377 THR C 387 1 11 HELIX 16 16 VAL C 399 GLU C 404 1 6 HELIX 17 17 PHE C 407 MET C 411 5 5 HELIX 18 18 ASP C 416 HIS C 428 1 13 HELIX 19 19 GLY C 432 CYS C 440 1 9 HELIX 20 20 THR C 447 ARG C 456 1 10 HELIX 21 21 ASN C 457 GLY C 469 1 13 HELIX 22 22 THR C 470 ILE C 474 5 5 HELIX 23 23 ASP C 475 GLU C 483 1 9 HELIX 24 24 GLY C 492 GLY C 509 1 18 HELIX 25 25 SER C 521 ALA C 529 1 9 HELIX 26 26 SER C 532 THR C 541 1 10 HELIX 27 27 SER C 565 LEU C 567 5 3 HELIX 28 28 LEU C 572 ARG C 576 5 5 HELIX 29 29 LEU B 60 VAL B 69 1 10 HELIX 30 30 PRO B 72 LEU B 76 5 5 HELIX 31 31 LEU B 84 ASP B 98 1 15 HELIX 32 32 ALA D 173 GLY D 178 1 6 HELIX 33 33 GLU D 180 LEU D 187 1 8 HELIX 34 34 ASP D 219 THR D 224 1 6 HELIX 35 35 MET D 243 ASN D 268 1 26 HELIX 36 36 ASP D 272 ASP D 295 1 24 HELIX 37 37 ASP D 295 GLY D 302 1 8 HELIX 38 38 LEU D 301 LEU D 310 1 10 HELIX 39 39 VAL D 327 PHE D 332 1 6 HELIX 40 40 ARG D 333 ILE D 339 5 7 HELIX 41 41 SER D 362 VAL D 364 5 3 HELIX 42 42 SER D 368 GLU D 374 1 7 HELIX 43 43 ILE D 377 ALA D 386 1 10 HELIX 44 44 VAL D 399 GLU D 404 1 6 HELIX 45 45 PHE D 407 MET D 411 5 5 HELIX 46 46 ASP D 416 HIS D 428 1 13 HELIX 47 47 GLY D 432 CYS D 440 1 9 HELIX 48 48 THR D 447 ARG D 456 1 10 HELIX 49 49 ASN D 457 GLY D 469 1 13 HELIX 50 50 THR D 470 ILE D 474 5 5 HELIX 51 51 ASP D 475 GLU D 483 1 9 HELIX 52 52 GLY D 492 GLY D 509 1 18 HELIX 53 53 SER D 521 ALA D 529 1 9 HELIX 54 54 SER D 532 THR D 541 1 10 HELIX 55 55 SER D 565 LEU D 567 5 3 HELIX 56 56 LEU D 572 ARG D 576 5 5 SHEET 1 A 2 ARG A 27 ALA A 28 0 SHEET 2 A 2 ILE C 164 ASN C 165 -1 N ASN C 165 O ARG A 27 SHEET 1 B 2 PRO A 78 SER A 83 0 SHEET 2 B 2 PRO C 388 LYS C 390 -1 O ALA C 389 N ASP A 79 SHEET 1 C 2 LEU C 128 LYS C 129 0 SHEET 2 C 2 CYS C 143 ILE C 144 -1 O ILE C 144 N LEU C 128 SHEET 1 D 2 PHE C 342 PHE C 344 0 SHEET 2 D 2 ARG C 358 PRO C 360 -1 O VAL C 359 N MET C 343 SHEET 1 E 2 THR C 545 SER C 547 0 SHEET 2 E 2 PHE C 561 ASN C 563 -1 N VAL C 562 O VAL C 546 SHEET 1 F 2 ARG B 27 ALA B 28 0 SHEET 2 F 2 ILE D 164 ASN D 165 -1 N ASN D 165 O ARG B 27 SHEET 1 G 2 PRO B 78 SER B 83 0 SHEET 2 G 2 PRO D 388 LYS D 390 -1 O ALA D 389 N ASP B 79 SHEET 1 H 2 LEU D 128 LYS D 129 0 SHEET 2 H 2 CYS D 143 ILE D 144 -1 O ILE D 144 N LEU D 128 SHEET 1 I 2 PHE D 342 PHE D 344 0 SHEET 2 I 2 ARG D 358 PRO D 360 -1 O VAL D 359 N MET D 343 SHEET 1 J 2 THR D 545 SER D 547 0 SHEET 2 J 2 PHE D 561 ASN D 563 -1 N VAL D 562 O VAL D 546 SSBOND 1 CYS A 1 CYS A 14 1555 1555 1.98 SSBOND 2 CYS C 115 CYS C 125 1555 1555 2.08 SSBOND 3 CYS C 119 CYS C 143 1555 1555 2.05 SSBOND 4 CYS C 153 CYS D 153 1555 1555 2.05 SSBOND 5 CYS C 221 CYS C 232 1555 1555 2.00 SSBOND 6 CYS C 440 CYS C 497 1555 1555 2.01 SSBOND 7 CYS C 538 CYS C 564 1555 1555 2.03 SSBOND 8 CYS B 1 CYS B 14 1555 1555 1.99 SSBOND 9 CYS D 115 CYS D 125 1555 1555 2.04 SSBOND 10 CYS D 119 CYS D 143 1555 1555 2.07 SSBOND 11 CYS D 221 CYS D 232 1555 1555 2.03 SSBOND 12 CYS D 440 CYS D 497 1555 1555 2.02 SSBOND 13 CYS D 538 CYS D 564 1555 1555 2.03 LINK OD1 ASP A 94 CMD HEM A 605 1555 1555 1.55 LINK CMB HEM A 605 OE2 GLU C 242 1555 1555 1.55 LINK CBB HEM A 605 SD MET C 243 1555 1555 1.62 LINK C SER C 149 N CSO C 150 1555 1555 1.33 LINK C CSO C 150 N PRO C 151 1555 1555 1.34 LINK ND2 ASN C 189 C1 NAG C1620 1555 1555 1.43 LINK ND2 ASN C 225 C1 NAG C1630 1555 1555 1.46 LINK ND2 ASN C 317 C1 NAG E 1 1555 1555 1.46 LINK OD1 ASP B 94 CMD HEM B 605 1555 1555 1.56 LINK CMB HEM B 605 OE2 GLU D 242 1555 1555 1.56 LINK CBB HEM B 605 SD MET D 243 1555 1555 1.61 LINK C SER D 149 N CSO D 150 1555 1555 1.34 LINK C CSO D 150 N PRO D 151 1555 1555 1.35 LINK ND2 ASN D 189 C1 NAG D2620 1555 1555 1.45 LINK ND2 ASN D 225 C1 NAG D2630 1555 1555 1.46 LINK ND2 ASN D 317 C1 NAG F 1 1555 1555 1.45 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.38 LINK O6 NAG E 1 C1 FUC E 6 1555 1555 1.39 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.39 LINK O3 BMA E 3 C1 MAN E 4 1555 1555 1.38 LINK O6 BMA E 3 C1 MAN E 5 1555 1555 1.40 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.38 LINK O6 NAG F 1 C1 FUC F 6 1555 1555 1.41 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.38 LINK O3 BMA F 3 C1 MAN F 4 1555 1555 1.39 LINK O6 BMA F 3 C1 MAN F 5 1555 1555 1.40 LINK O ASP A 96 CA CA C1600 1555 1555 2.40 LINK OD2 ASP A 96 CA CA C1600 1555 1555 2.48 LINK FE HEM A 605 C CYN A1844 1555 1555 2.06 LINK FE HEM A 605 N CYN A1844 1555 1555 2.81 LINK FE HEM A 605 NE2 HIS C 336 1555 1555 2.18 LINK O THR C 168 CA CA C1600 1555 1555 2.34 LINK OG1 THR C 168 CA CA C1600 1555 1555 2.39 LINK O PHE C 170 CA CA C1600 1555 1555 2.27 LINK OD1 ASP C 172 CA CA C1600 1555 1555 2.41 LINK OG SER C 174 CA CA C1600 1555 1555 2.53 LINK O ASP B 96 CA CA D2600 1555 1555 2.23 LINK OD2 ASP B 96 CA CA D2600 1555 1555 2.57 LINK FE HEM B 605 C CYN B2844 1555 1555 2.01 LINK FE HEM B 605 N CYN B2844 1555 1555 2.90 LINK FE HEM B 605 NE2 HIS D 336 1555 1555 2.24 LINK O THR D 168 CA CA D2600 1555 1555 2.24 LINK OG1 THR D 168 CA CA D2600 1555 1555 2.28 LINK O PHE D 170 CA CA D2600 1555 1555 2.37 LINK OD1 ASP D 172 CA CA D2600 1555 1555 2.54 LINK OG SER D 174 CA CA D2600 1555 1555 2.25 CISPEP 1 PRO C 123 PRO C 124 0 0.21 CISPEP 2 GLU C 354 PRO C 355 0 0.58 CISPEP 3 ASN C 549 ASN C 550 0 1.08 CISPEP 4 TYR C 557 PRO C 558 0 1.74 CISPEP 5 PRO D 123 PRO D 124 0 0.29 CISPEP 6 GLU D 354 PRO D 355 0 0.65 CISPEP 7 ASN D 549 ASN D 550 0 -0.68 CISPEP 8 TYR D 557 PRO D 558 0 0.59 CRYST1 111.338 63.324 92.263 90.00 97.41 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008982 0.000000 0.001168 0.00000 SCALE2 0.000000 0.015792 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010930 0.00000 MTRIX1 1 -0.606400 0.681360 -0.409900 48.13749 1 MTRIX2 1 0.686270 0.188080 -0.702610 -7.20248 1 MTRIX3 1 -0.401640 -0.707370 -0.581650 34.41179 1